Home » Topics » Regulatory » Patents

Patents
RSS

Alchemedicine discovers CK1 and/or TGFBR1 inhibitors

Jan. 13, 2022

Roche synthesizes new Mat2A inhibitors

Jan. 13, 2022

AstraZeneca identifies new PARP-1 inhibitors

Jan. 13, 2022

Merck Sharp & Dohme presents new SCN10A blockers

Jan. 13, 2022

Autobahn Therapeutics patents thyroid hormone receptor agonists

Jan. 13, 2022

Wigen Biomedicine Technology presents new CDK inhibitors

Jan. 12, 2022

Betta Pharmaceuticals synthesizes new HIF-2alpha inhibitors

Jan. 12, 2022

Abbisko Therapeutics identifies new PD-1/PD-L1 interaction inhibitors

Jan. 12, 2022

Anaxis Pharma patents MLKL inhibitors

Jan. 12, 2022

Leo Pharma discloses IL-17 modulators

Jan. 12, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...